A clinical study to evaluate the effect of Haridradi Vaginal Pessary in Vaginal Candidiasis
Phase 1
- Conditions
- Health Condition 1: N898- Other specified noninflammatory disorders of vagina
- Registration Number
- CTRI/2023/05/052592
- Lead Sponsor
- SANE GURUJI AROGYA KENDRA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
MARRIED WOMEN BETWEEN 20 TO 60 YEARS OF AGE DIAGNOSED WITH KAPHAJ YONIVYAPAD WITH CLINICAL FEATURES OF KANDU,SHWETA-SHEET,PICCHIL YONISTRAV AND ALPAVEDANA
Exclusion Criteria
1.PREGNANCY
2.DRUG ALLERGY
3.SYSTEMIC DISEASES-DM,TB,STD,HIV,PID
4.PV BLEEDING
5.MALIGNANT DISEASES OF GENITAL TRACT
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO EVALUATE THE EFFECT OF HARIDRADI VAGINAL PESSARY IN KAPHAJ YONIVYAPAD. <br/ ><br>ASSESSMENT OF VAGINAL DISCHARGE QUANTITY,CONSISTENCY,ITCHING,SMELL AND PAIN.Timepoint: TREATMENT WILL BE GIVEN FOR CONSECUTIVE 7 DAYS. <br/ ><br>ASSESSMENT WILL BE DONE ON 1,2,3,4,5,6 AND 7TH DAY. <br/ ><br>FOLLOW UP WILL BE TAKEN ON 15TH DAY
- Secondary Outcome Measures
Name Time Method 1.LITERATURE STUDY OF KAPHAJ YONIVYAPAD. <br/ ><br>2.STANDARD PROCEDURE FOR PREPARATION OF HARIDRADI VAGINAL PESSARY. <br/ ><br>3.RAW DRUG WILL BE AUTHENTICATE AND STANDARDISATION <br/ ><br>4.CLINICAL TRAIL AND DATA COLLECTION <br/ ><br>5.STATISTICAL ANALYSIS AND CONCLUSION <br/ ><br>6.TO OBSERVE ADVERSE EFFECT IF ANYTimepoint: 1.STUDY WILL BE DONE USING AYURVEDIC GRANTHAS AND MODERN TEXTS IN 1 MONTH. <br/ ><br>2.WILL BE STUDIED WITHIN 1 MONTH. <br/ ><br>3.WILL BE DONE IN 1 MONTH. <br/ ><br>4.WILL BE DONE IN 10 MONTHS. <br/ ><br>5.WILL BE DONE IN 1 MONTH <br/ ><br>6.DURING TREATMENT OBSERVATION WILL BE DONE FOR ANY ADVERSE EFFECT ON PATIENTS